The present invention relates to small molecule compounds and their use as HDAC inhibitors and in the treatment of various diseases, such as cancer. The present invention further relates to methods of synthesizing the compounds and methods of treatment. H-L(HA), H is a head group selected from (head group 1), (head group 2), (head group 3), (head group 4), (head group 5) and (head group 6).
BRANA, MIGUEL F.;GARRIDO, MERCEDES;RODRIGUEZ, MARIA L. LOPEZ;MIGUEL, PILA+, J. HETEROCYCL. CHEM., 27,(1990) N, C. 703-706
作者:BRANA, MIGUEL F.、GARRIDO, MERCEDES、RODRIGUEZ, MARIA L. LOPEZ、MIGUEL, PILA+
DOI:——
日期:——
BRANA, MIGUEL F.;GARRIDO, MERCEDES;LOPEZ, M. LUZ;DE, MIGUEL PILAR;RIANO, +, SYNTH. COMMUN., 20,(1990) N2, C. 1793-1810
作者:BRANA, MIGUEL F.、GARRIDO, MERCEDES、LOPEZ, M. LUZ、DE, MIGUEL PILAR、RIANO, +
DOI:——
日期:——
NOVEL HDAC6 INHIBITORS AND THEIR USES
申请人:Universität Regensburg
公开号:EP3177621B1
公开(公告)日:2021-11-10
Synthesis of new derivatives of β-carboline-hydantoin
作者:Miguel F. Braña、Mercedes Garrido、María L. López Rodriguez、Pilar Miguel、M. José Morcillo、A. Riaño
DOI:10.1002/jhet.5570270342
日期:1990.3
Reaction of tetrahydro-β-carboline-3-carboxylic acids 4a-c with alkyl and phenyl isocyanates in acetone provide the corresponding 2,5-disubstituted 1,3-dioxo-6H-1,2,3,5,11,11a-hexahydroimidazo[1,5-b]-β-carbolines 2a-r.
四氢-β-咔啉-3-羧酸4a-c与烷基和苯基异氰酸酯在丙酮中的反应提供相应的2,5-二取代的1,3-二氧代-6 H -1,2,3,5,11,11a -六氢咪唑并[1,5 - b ]-β-咔啉2a-r。